ADC Therapeutics S.A. ( ADCT) - Stock Earnings
ADCT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -41.0 million USD | 16.4 million USD |
| 2025Q4 | -6.4 million USD | 23.1 million USD |
| 2026Q1 | -33.0 million USD | 20.9 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
ADCT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -240.1 million USD | 69.6 million USD |
| 2024 | -157.8 million USD | 70.8 million USD |
| 2025 | -142.6 million USD | 81.4 million USD |
| 2026 Est. | — | — |
ADCT
Price: $3.08
52 week price:
Earnings Per Share: -0.97 USD
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Country: Switzerland
Volume: 1.0 million
Market Capitalization: 445.2 million